Dong-a Pharmaceutical Co., Ltd

Lg Electronics Inc.

Dong-a St Co., Ltd.

Dong-a Pharm. Co., Ltd.

Woo Young Kwak

Moohi Yoo

Heung Jae Kim

Tae Hyun Yoon

Jong Pil Min

Soon Hoe Kim

Chang Yell Shin

Moon-Ho Son

Song-Hyen Choi

Geun Gho Lim

Mi-Kyung Kim

Jae Young Lee

Min-Jung Lee

Sun Ki Chang

Ji-Su Kim

Sun-Ho Choi

Hyun Joo Shim

Yu Na Chae

Kyung Seok Lee

Kyung Jin Park

Eun Kyoung Yang

Chang-Yong Shin

Ji Myun Jang

Punna Reddy Ullapu

Hae-Sun Kim

Hadong Kim

Gook Jun Ahn

Joong In Lim

Soon Kyu Jung

Ullapu Punna Reddy

Tae Sun Park

The present invention relates to a novel salt of (R)-(1-methylpyrrolidine-3-yl)methyl(3'-chloro-4&#x2032;-fluoro-[1,1&#x2032;-biphenyl]-2-yl)carbamate and a crystal form thereof. Also, the novel salt of (R)-(1-methylpyrrolidine-3-yl)methyl(3&#x2032;-chloro-4&#x2032;-fluoro-[1,1&#x2032;-biphenyl]-2-yl)carbamate and the crystal form thereof according to examples of the present invention have remarkably excellent stability, hygroscopicity and solubility.

Salt of (R)-(-methylpyrrolidine--yl)methyl(-chloro--fluoro-[-biphenyl]--yl)carbamate and crystal form thereof

The present invention relates to a method for preparing N-[[1-{3-(1,2,3-triazol-1-yl)propyl}piperidin-4-yl]methyl]-4-amino-5-chloro-2-methoxybenzamide, which is a novel benzamide derivative as a 5-HT4 receptor agonist, or a pharmaceutically acceptable salt thereof; to a novel intermediate capable of being used in the preparation of the compounds; and to a method for preparing the same. The preparation methods of the present invention can be useful for mass production since a low-priced reagent and intermediate are used and the number of reaction processes is decreased, thereby saving preparation costs and improving the yield.

Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate

The present invention relates to an improved method for preparing dipeptidyl peptidase-IV inhibitor intermediates. The present invention is able to reduce preparation costs by using low cost reagents on reaction and is able to be used in mass production by improving yield.

Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate

The present invention relates to an improved method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate. The present invention allows reduction of production costs by reacting low cost reagents, improves yield and is adaptable for mass production.

Method for manufacturing dipeptidyl peptidase-IV inhibitor and intermediate

The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a compound which inhibits the activity of dipeptidyl peptidase-IV (DPP-IV), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and one or more other antidiabetic or antiobesity agents. The pharmaceutical composition exhibits excellent glucose tolerance and may be useful in the prevention and treatment of diabetes, obesity, and the like by effectively inhibiting blood glucose levels and reducing fat mass.

Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients

The present invention provides a novel heterocyclic compound containing a beta-amino group, a method for preparing the same, and a pharmaceutical composition comprising the same heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient. The heterocyclic compound of the present invention exhibits excellent DPP-IV inhibitory activity and bioavailability and therefore can be useful for the prophylaxis or treatment of DPP-IV-related diseases such as diabetes or obesity.

DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity

One piece type or integrated wireless local loop (WLL) terminal has a speaker, a microphone, and a built-in or integrated USB (Universal Serial Bus) and USB driver in the terminal. The WLL terminal is capable of being used with a charger that has connectors for connecting the USB line driver and the USB of the terminal with an external device, such as a personal computer.

Integrated wireless local loop system

A cordless communication apparatus which improves the performance of data transmission and reception by preventing the bandpass loss and the deterioration of frequency characteristics, which are caused during coupling a transmission output unit and reception input unit for using a single antenna. The apparatus minimizes power consumption, which is produced in using a .lambda./4 transmission path, thereby improving communication sensitivity. Also, since an expensive duplexer filter is not used, the manufacturing cost is reduced, thereby improving the price competitiveness of products.

Transmission and reception matching method for a cordless communication

Growing community of inventors

Yongin-si, South Korea

Woo Young Kwak